Scopus BioPharma Inc. (SCPS)

OTCMKTS · Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
At close: Feb 27, 2026
Market Cap16.83K -99.1%
Revenue (ttm)n/a
Net Income-8.70M
EPS-0.31
Shares Out42.08M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume865
Average Volume3,361
Open0.0004
Previous Close0.0004
Day's Range0.0004 - 0.0006
52-Week Range0.0003 - 0.0100
Beta31.08
RSI47.13
Earnings DateApr 16, 2026

About Scopus BioPharma

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs. It offers Duet Platform, which consists of signal transducer and activator of transcription 3 (STAT3), a master immune checkpoint inhibitor and toll-like receptor 9 (TLR9), as well as includes CpG-STAT3ASO (DUET-02), CpG-STAT3siRNA (DUET-01), and CpG-STAT3decoy (DUET-03); and that develops a suite of bifunctional oligonucleotides that activate antigen-presenting cells (APCs) ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 13
Stock Exchange OTCMKTS
Ticker Symbol SCPS
Full Company Profile

Financial Performance

Financial Statements